Abbott price target raised to $145 from $140 at RBC Capital

RBC Capital raised the firm’s price target on Abbott (ABT) to $145 from $140 and keeps an Outperform rating on the shares. The company’s Q1 results represented strong underlying business trends against the current macro backdrop, and the firm believes that the 8.3% y/y underlying growth with double-digit EPS growth for the business is notable off of its large revenue base, the analyst tells investors in a research note. RBC adds that it remains encouraged with Abbott’s strong high-single digit revenue and double-digit EPS growth as it absorbs tariffs while maintaining full year guide.